Immunology Laboratory Billing Services

Experienced Immunology Laboratory Billing Services

TransLabs delivers comprehensive billing and revenue cycle management services designed exclusively for flow cytometry and immunology laboratories performing immunophenotyping, lymphocyte subset analysis, minimal residual disease monitoring, cell marker quantification, HLA typing, crossmatching, and advanced immunological function testing.
Years Serving Laboratories
0 +
Claims Processed Annually
0 M+
Client Retention Rate
0 %
Turn Around Time (TAT)
Hours

The TransLabs Immunology Diagnostics Laboratory Advantage

Flow cytometry and immunology laboratory billing requires specialized expertise in multi-parameter panel coding, professional versus technical component separation, and evolving payer coverage. TransLabs’ certified specialists manage multi-marker panel optimization, interpretation versus technical service billing, MRD monitoring protocols, cell enumeration coding, and prior authorization requirements to maximize reimbursement and eliminate revenue loss.

Our Performance Metrics Demonstrate Excellence:

First-Pass Claim Rate
0 %
Avg. Reduction in Days in A/R
0 %
Avg. Revenue Growth
8 - 9 %
Payers in Network
0 +

Understanding Immunology Laboratory Billing Challenges

Flow cytometry and immunology laboratory billing manages the full revenue cycle for cellular and immune function testing, including immunophenotyping, MRD monitoring, HLA typing, and functional immune assessment. These labs face unique coding and reimbursement challenges. TransLabs specializes in these challenges:

TransLabs specializes in these unique Molecular Diagnostics & Genetics challenges:

Multi-Parameter Panel Complexity

Expert coding for immunophenotyping panels analyzing 8-12+ markers with modifier application.

Professional vs. Technical Component

Sophisticated separation of pathologist interpretation from technical analysis.

Prior Authorization Excellence

93% approval rate for hematologic malignancy panels, HLA typing, and immune function testing.

Indication-Specific Coverage

Expert understanding of coverage for malignancy diagnosis, MRD monitoring, and immunodeficiency.

Specimen-Type Code Selection

Accurate CPT assignment based on specimen source (blood, bone marrow, body fluids, tissue).

MRD Monitoring Protocol

Systematic billing for MRD testing with frequency tracking and medical necessity documentation.

TransLabs Provides Coverage Across All Laboratory Payors

From commercial insurers to Medicare and Medicaid, our specialists have the lab-exclusive billing expertise to get your claims paid across every network, every time.

Anthem Insurance Aetna Insurance Wellcare Health Insurance Kaiser Permanente Health Insurance Cigna Health Insurance Molina Healthcare Insurance Health Net Insurance Medicaid Government Health Insurance United Healthcare Insurance Humana Health Insurance Blue Cross Blue Shield Insurance Centene Corporation Insurance Oscar Health Insurance Tricare Military Health Insurance Medicare Federal Health Insurance Anthem Insurance Aetna Insurance Wellcare Health Insurance Kaiser Permanente Health Insurance Cigna Health Insurance Molina Healthcare Insurance Health Net Insurance Medicaid Government Health Insurance United Healthcare Insurance Humana Health Insurance Blue Cross Blue Shield Insurance Centene Corporation Insurance Oscar Health Insurance Tricare Military Health Insurance Medicare Federal Health Insurance

Complete RCM Services Across All Immunology Disciplines

TransLabs provides expert billing and coding for the full spectrum of flow cytometry and immunology laboratory testing:

  • Acute leukemia immunophenotyping (AML, ALL)
  • Chronic lymphoproliferative disorder panels (CLL, NHL)
  • Lymphoma immunophenotyping
  • Multiple myeloma phenotyping
  • Myelodysplastic syndrome (MDS) panels
  • Myeloproliferative neoplasm analysis
  • Plasma cell dyscrasia evaluation
  • Hairy cell leukemia immunophenotyping
  • Large granular lymphocyte (LGL) analysis
  • Sézary syndrome/mycosis fungoides panels
  • Acute leukemia MRD (multi-color flow)
  • Multiple myeloma MRD monitoring
  • Chronic lymphocytic leukemia (CLL) MRD
  • Post-transplant MRD surveillance
  • Treatment response assessment
  • Pre-transplant disease burden quantification
  • Serial MRD tracking for relapse detection
  • Risk stratification MRD panels
  • CD4/CD8 T cell quantification (HIV monitoring)
  • Absolute lymphocyte subset counts
  • T cell, B cell, NK cell enumeration
  • Regulatory T cell (Treg) quantification
  • Memory T cell subset analysis
  • Naïve vs. effector T cell distribution
  • Helper T cell subset analysis (Th1, Th2, Th17)
  • Activated lymphocyte markers
  • Primary immunodeficiency screening panels
  • Common variable immunodeficiency (CVID) workup
  • Severe combined immunodeficiency (SCID) evaluation
  • DiGeorge syndrome immunophenotyping
  • Wiskott-Aldrich syndrome evaluation
  • X-linked agammaglobulinemia assessment
  • Hyper-IgM syndrome testing
  • Chronic granulomatous disease (CGD) screening
  • Leukocyte adhesion deficiency testing
  • CD34+ stem cell enumeration
  • Hematopoietic progenitor cell quantification
  • Apheresis product analysis
  • Cord blood stem cell assessment
  • Post-transplant chimerism monitoring
  • Graft-versus-host disease (GVHD) evaluation
  • Engraftment monitoring
  • Immune reconstitution assessment
  • HLA Class I typing (A, B, C)
  • HLA Class II typing (DR, DQ, DP)
  • High-resolution HLA typing
  • Flow cytometry crossmatching (FCXM)
  • Virtual crossmatching support
  • Donor-specific antibody (DSA) assessment
  • Panel reactive antibody (PRA) testing
  • HLA antibody identification
  • T cell proliferation assays
  • NK cell cytotoxicity testing
  • Neutrophil oxidative burst (DHR assay)
  • Basophil activation testing
  • Platelet function analysis by flow cytometry
  • Apoptosis assays
  • Cell cycle analysis
  • Intracellular cytokine detection
  • High-sensitivity PNH screening
  • PNH clone quantification (red cells)
  • PNH granulocyte analysis
  • PNH monocyte evaluation
  • CD55/CD59 deficiency detection
  • FLAER-based PNH testing
  • Serial PNH monitoring

Specialized Services For Immunology Labs Nationwide:

Proficient Across Multiple LIS & EHRs to Simplify Your

Laboratory Management

Athena Orchard Eclinical Works Novopath Psyche Systems Veradigm Clinisys Athena Orchard Eclinical Works Novopath Veradigm Clinisys

Why Immunology Laboratories Choose TransLabs

Flow Cytometry Specialization

Expert in multi-parameter panel coding and MRD monitoring protocols.

PC Expertise

Expert pathologist interpretation billing and diagnostic correlation documentation.

Prior Authorization Excellence

93% approval rate for malignancy panels, HLA typing, and MRD monitoring.

Multi-Marker Panel Optimization

Strategic panel coding maximizing reimbursement.

High-Dollar Claim Management

Purpose-built systems with reagent cost documentation and appeal-ready protocols.

Proven Immunology Lab Results

98% clean claims, 30% A/R reduction, $150K-$500K revenue increases.

TransLabs' Immunology Laboratory Billing Best Practices

TransLabs optimizes your flow cytometry and immunology laboratory revenue cycle through systematic best practices that ensure maximum reimbursement and operational efficiency.

Professional/Technical Component Optimization

Establish pathologist interpretation documentation, implement 26 modifier application, and separate professional and technical claim submission for optimal reimbursement.

Multi-Parameter Panel Strategic Coding

Document each marker with clinical rationale, apply appropriate CPT codes, and utilize correct modifiers (59, XE, XS, XP, XU).

Proactive Prior Authorization Management

Identify PA requirements at order entry, submit authorizations with comprehensive justification before processing, and track approval status in real-time.

Specimen-Specific Code Selection

Apply correct CPT codes based on specimen type, document specimen adequacy, and prevent downcoding through precise documentation.

MRD Monitoring Protocol Documentation

Establish systematic MRD frequency protocols, document baseline markers for serial monitoring, and coordinate with oncology for treatment documentation.

Frequently Ask Question

How do you handle professional versus technical component billing for flow cytometry?

TransLabs systematically separates professional and technical components, ensuring pathologist documentation meets payer standards, applying 26 modifiers correctly, and coordinating between laboratory and pathology billing to prevent missed charges. Our clients typically see 22-30% revenue increases through proper professional component capture.

Yes. We maintain current PA requirement matrices for all major payers, identify PA needs at order entry, and submit comprehensive clinical justification before processing. We achieve 93% approval rates across all panel types and appeal denials with medical necessity documentation and peer-reviewed literature.

We apply all appropriate CPT codes for each marker, use correct modifiers (59, XS, XE, XP, XU), and maintain disease-specific panel templates with medical necessity justification. Our panel optimization typically increases flow cytometry revenue by 25-40% through proper marker coding and denial prevention.

TransLabs maintains disease-specific MRD protocols, tracks testing frequency to prevent coverage violations, and coordinates with oncology for treatment documentation. Our expertise prevents the high denial rates (35-45%) labs without specialized knowledge commonly experience.

Yes. We integrate with all major LIS platforms including EPIC Beaker, Sunquest, Cerner, Soft Computer, and Meditech, enabling automated charge capture, real-time code assignment, and seamless professional/technical coordination without changing your existing systems.

We maintain current HLA and transplant immunology CPT codes, implement proactive prior authorization for high-resolution typing and crossmatching, and coordinate with transplant coordinators for medical necessity documentation.

Please Fill out the Form

What Our Clients Say?

Linda Hutchinson
Linda Hutchinson
Laboratory Director
Our NGS panel denials dropped from 32% to under 6% within three months. TransLabs' expertise with molecular tier codes, prior authorization management, and LCD compliance has been invaluable. They understand the nuances of genetic testing billing that our previous vendor completely missed.
Peter Wozniak
Peter Wozniak
Pathologist & Laboratory Owner
We've worked with three other billing companies over the years. TransLabs is the only one that truly understands complex surgical pathology coding, immunohistochemistry billing, and the nuances of TC/PC modifiers. Clean claims rate improved to 99%, and our dermatopathology reimbursement increased 27%.
James Patton
James Patton
Cytogenetics Laboratory Manager
Before TransLabs, our FISH and karyotype claims were a constant struggle with denials and underpayments. Their coders actually understand probe configurations, complexity levels, and when to use 88271 versus 88275. Our cytogenetics revenue increased 34% in the first year.